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ABSTRACT 
Cell adhesion molecules mediate specific cell-cell interactions during 
embryogenesis and tissue formation. Among cell-cell adhesion molecules 
(CAMs), we have been particularly interested in the neural cell adhesion 
molecule (NCAM) which is the prototypical member of the family of Ca++ -
independent CAMs. Previous studies of NCAM cDNAs have revealed an 
alternatively spliced set of small exons (12A, 12B, 12C, 12D) that encode a 
region in the extracellular portion of the molecule known as the muscle 
specific domain (MSD). The entire MSD region can be expressed in skeletal 
muscle, heart, and skin; only exons 12A and 12D have been found in brain. 
These studies, however, did not reveal which NCAM polypeptides contain 
the MSD region or the immunohistochemical distribution of these NCAM 
molecules. To address these questions, we prepared antibodies against the 
oligopeptides encoded by exons 12A and 12B and by exons 12C and 12D and 
used these antibodies to study the forms of NCAM containing the MSD 
region expressed during embryonic chicken heart development. These 
antibodies recognize certain forms of NCAM found in the heart but do not 
recognize brain NCAM. In the heart, each of the splice variants of NCAM (ld, 
sd, and ssd) that differ in their mode of attachment to the plasma membrane 
or in the size of their cytoplasmic domain is expressed in a form containing 
and in a form lacking the MSD region. No microheterogeneity is observed in 
XIII 
the size of NCAM molecules containing the MSD region, even at the level of 
CNBr fragments, suggesting that exons 12A-D are expressed as a single unit. 
We have identified six different isoforms of heart NCAM which exhibit 
changing temporal and spatial patterns of expression during development: 
the three forms of NCAM, ld, sd, and ssd, can also be expressed in a form 
containing the MSD sequence. Depending on the site and the stage of 
development, the percentage of NCAM molecules containing the MSD 
region can vary from nearly a to 100 percent. In general, this percentage 
increases during development. In immunohistochemical studies of hearts 
from stage 18 embryos, forms of NCAM containing the MSD regIon 
colocalized with Z-discs. No other adhesion molecules were found in this 
distribution at this early stage of development. Studies on isolated cells in 
vitro demonstrate that the colocalization with Z discs of NCAM molecules 
containing the MSD region does not depend on cell-cell contact and raise the 
possibility that this form of NCAM is involved in cell-extracellular matrix 
interactions. The association of NCAM molecules containing the MSD 




NCAM, The Neural Cell Adhesion Molecule 
The cellular and molecular processes of development within an 
organism involve series of biological changes. Initiation or progression of 
each developmental event such as cell migration, proliferation, or tissue 
differentiation is precisely programmed to be coordinated in time and space. 
It has been demonstrated that cell adhesions are important contributors to the 
estabishment of form and pattern during development (17, 74). In general, 
adhesion occur by two ways, cell-cell interactions or cell-extracellular matrix 
interactions. These interactions are based on specific adhesion molecules, cell 
adhesion molecules (CAMs) and cell-substrate adhesion molecules (SAMs). 
CAMs are membrane receptors that mediate cell-to-cell adhesion by their 
interactions at the cell surface. CAMs are largely divided into two groups 
accordirlg to their Ca++ -dependence: the Ca++ -dependent adhesion molecules 
known as cadherins and the Ca++ -independent adhesion molecules including 
the neural cell adhesion molecule (NCAM) (17, 32, 74). SAMs mediate cell-to-
extracellular matrix (ECM) adhesion by the interactions of extracellular matrix 
proteins with their cell surface receptors (14, 18, 20, 24). At the functional 
level, adhesion molecules specifically control cell behavior both directly and 
1 
indirectly. That is, adhesion molecules directly mediate the cell migration 
and maintain tissue borders at the surface of cells, and at the same time 
adhesion molecules indirectly affect the fate of cells through the 
transmembrane signal transduction mechanisms their binding initiates (11, 
17, 33, 36, 65, 70). 
Among the cell adhesion molecules, NCAM has been of particular 
interest to us. NCAM mediates cell-cell adhesion both by a homophilic 
mechanism (31, 52, 61, 62), i.e., NCAM to NCAM, and by heterophilic 
mechanisms involving the interaction of a heparin-binding domain in 
NCAM with heparan sulfate proteoglycans (57) or the interaction of NCAM 
with neurocan, a chondroitin sulfate proteoglycan (54). NCAM is expressed 
in a number of cell types including neuron, skeletal muscle, heart, kidney, 
liver, gizzard, ovary, skin, testis, and lymphocyte (2, 10, 65). It is present 
abundantly in various tissues from very early embryos through adults (2, 17). 
It plays major morphoregulatory roles in guiding tissue formation and 
differentiation (2, 17). NCAM is structural diverse (46). It contains a large 
number of unusual polysialic acid (PSA) side chains that are important for its 
adhesive function (1, 9, 17, 32). 
Structural Diversity of the NCAM Polypeptide 
NCAM was the first cell adhesion molecule to be identified. It is a cell 
surface glycoprotein containing large amonts of polysialic acid (PSA). PSA is 
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composed of unIque a-2,8-linked oligo saccharides that are rare in other 
molecules (9, 21, 60). One type of NCAM heterogeneity is due to differential 
polysialylation. Polysialylation modulates NCAM adhesion (I, 31) and the 
level of polysialylation of NCAM correlates with development of an 
organism (13, 21, 31, 32). 
Another type of heterogeneity IS found in the NCAM poypeptide. 
NCAM belongs to the IgG superfamily, containing immunoglobulin (IgG)-
homologous domains. The extracellular structure is well conserved in all 
NCAM species: there are five IgG-domains and two fibronectin type III 
homologous repeats (9, 32) (Figure 1). In contrast, the cytoplasmic portion of 
NCAM exhibits a great deal of structural heterogeneity. One form of NCAM, 
ssd (small surface domain), is covalently linked to the plasma membrane via 
glycolipid glycosyl-phosphatidylinositol (GPI); two integral membrane forms, 
ld (large domain) and sd (small domain), differ in the size of their cytoplasmic 
domains (3, 27, 28, 46, 62). These various forms of NCAM are produced by 
alternative mRNA splicing from a single gene. Studies have shown that 
forms of NCAM vary according to the tissue type. The ld form is a major 
NCAM species in brain tissue, while sd or ssd are predominant in skeletal 
muscle. It has been predicted that tissue-specific modes of alternative splicing 
exist for NCAM synthesis. However, the molecular mechanism through 
which splicing occurs is still not known. 
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Figure 1. Models of three major NCAM Splice Variants. 
The structural diversity of NCAM largely divides into three groups as 
illustrated. All three forms are similar in their extracellular structure: five 
IgG homologous domains (hatched oval) at the N-terminus are followed by 
two fibronectin-like repeats (0). Unique polysialic acid side chains (9) are 
covalently bound to the IgG homologous domains. The NCAM splice 
variants differ in their mode of cell membrane attachment or in the 
truncation of transmembrane and/ or cytoplasmic region. While the ld (large 
domain) form contains an entire sequence encoded by all 19 exons, the sd 
(small domain) lacks the exon 18 (gray box)-encoded region, or the ssd (small 
surface domain) is only GPI-linked (staggered line) to the cell membrane 
(hatched box) with transmembrane and cytoplasmic regions exclusively 
truncated (see Figure 3 for more details). 
Figure source: Edelman & Crossin. 1991. "Cell adhesion molecules: 
implications for a molecular histology". Annu. Rev. Biochem. 
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NCAM Splice Variants with the MSD Region 
In addition, two small inserts in the NCAM polypeptide have been 
identified. They are spliced into two distinct locations in the extracellular 
portion of NCAM by alternative mRNA splicing. One is the VASE (variable 
alternatively spliced exon) insert that is present between the sequences 
encoded by exons 7 and 8 and is found in both brain and heart (64, 66, 67, 79). 
The other is the so-called muscle-specific domain or MSD region encoded by 
four small exons (12A, 12B, 12C, 12D) that are found between exons 12 and 13 
(51, 72) (Figure 2, 3). This insert is expected to be localized between two 
fibronectin homologous domains in the extracellular portion of NCAM. 
Because no reagents that recognize MSD polypeptide have been prepared 
previously, little was known of the distribution, structure, and function of 
MSD polypeptides. 
Molecular biology study based on RT-PCR (reverse transcriptase-based 
polymerase chain reaction) has suggested that the MSD is expressed in a 
variety of splice combinations of these four small exons (56). For example, 
only exons 12A and 12D from this region are expressed in the brain (26, 55, 
64), all four of these small exons are expressed in heart, skeletal muscle, and 
skin (IS, 43, 51). While the sequence of these four small exons is highly 
conserved between humans, rats, and mice, two of the four chicken exons 
(12A and 12B) are very different in sequence from their mammalian 
counterparts (51). 
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Figure 2. Structure of the NCAM Gene and an Intact NCAM Polypeptide. 
(A) The size and location of introns (0) and major exons (_) are 
indicated in the map. (B) The predicted structure of an intact NCAM 
polypeptide (B). The structure of ld (large cytoplasmic domain) species is 
illustrated. ld is the largest splice variant of NCAM which is encoded by the 
most of major 19 exons. The immunoglobulin homologous regions are 
shown (loops I-V). Alternative mRNA splicing can generate the other two 
major variants. The sd (small domain) transmembrane variant lacks the 
exon 18 sequence. The GPI-linked ssd (small surface domain) variant 
contains an extra sequence encoded by exon 15. kb = kilobase. 
Figure source: Cunningham, B. A. 1988. liThe structure and function 
of cell adhesion molecules". Advances in Cell BioI. 
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Figure 3. Schematic model of forms of NCAM produced by alternative 
mRNA splicing in the MSD and membrane attachment regions. 
Exon numbers encoding the various regions within the molecule are 
indicated. ld, sd, and ssd forms differ in their attachment to the membrane 
through the expression of transmembrane and cytoplasmic exons 16, 17, 18, 
and 19 or through the expression of exon 15 encoding a peptide that becomes 
covalently linked to CPI. The MSD region comprised of exons 12A, 12B, 12C, 
and 12D is expanded, the sequences of the peptides from this region used to 
immunize rabbits are shown in single-letter code. 
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In human skeletal muscle, the MSD comprises 37 amino acids and is 
encoded by at least three small exons of 15, 48, 42 bp at the junction of exons 
12 and 13 (15, 72). Similarly, chicken MSD is 31 amino acid sequence. This 
heart insert is encoded by a set of four exons, 12 A, B, C, and D of 15, 33, 42, 
and 3 bp, at the same genetic location (15, 51, 56, 64). 
Interestingly, mRNA encoding the MSD region of NCAM has been 
detected only in some tissues. The MSD exists in NCAM molecules produced 
in skeletal muscle, heart, and skin NCAM, but not in brain, gizzard, or liver. 
This suggests that the expression of MSD sequence is very tissue-specific (15, 
26, 43, 75, 78). 
Structural versus Functional Diversity of NCAM 
NCAM is a multifunctional adhesion molecule which can bind to 
more than one specific ligand. NCAM operates via both homophilic (31, 53, 
61, 62) and heterophilic binding mechanisms. That is, the NCAM binds to 
NCAM on apposing cells (31) as well as to other ligands such as heparin or 
heparan sulfate proteoglycan (57). Specific domains within NCAM mediating 
various types of NCAM interactions have begun to be uncovered by 
mutational analyses or by domain-targeted inhibition studies (53). However, 
very little is known about the importance of small structural motifs, VASE 
and MSD, that are present in NCAM. Functional studies on splice variants of 
NCAM suggest that the expression of the VASE insert inhibits neurite 
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outgrowth, while the MSD region has no effect on it (16). On the other hand, 
recent experiments suggest that the MSD insert found in the 125 kD NCAM 
played a role in myoblast fusion during myogenesis (49). These observations 
strongly suggest that inclusion of a small peptide motif significantly affects 
the NCAM function. Structural features of the MSD include consecutive 
proline residues as well as a-linked carbohydrate acceptor sites (75). 
The mode of association of NCAM with the cell membrane may also 
have functional consequences. A transfection study has shown that the GPI-
linked ssd form of NCAM is targeted to the apical surface of polarized 
epithelial cells differently than the transmembrane form (50). Others 
demonstrate that transmembrane forms of NCAM downregulate the 
secretion of a matrix metalloproteinase, gelatinase, while the GPI-linked form 
(125 kD) does not have this effect (19). 
Our studies have focused on the expressIon of the MSD insert in 
NCAM species. We have carefully examined the structural and functional 
alteration of NCAM in the presence of a MSD motif. We also have compared 
the spatial or temporal distribution of NCAM species in heart tissue and 
related their potential function to heart morphogenesis. 
NCAM Function and Heart Development 
There are many stages in early heart development when changes in the 
expression or function of cell-cell adhesion molecules may mediate or stablize 
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changes in morphology or may influence other developmental process. The 
best-known example of NCAM-mediated differentiation in the heart occurs 
during the formation of valves. 
Initially, the primitive heart (precardiac mesodermal epthelium) 
appears as paired primordia (6, 59). NCAM and N-cadherin are expressed on 
almost all of these cells (7, 40). Some of these precardiac cells deadhere as they 
downregulate expreSSIon of these adhesion molecules, convert into 
mesenchymal cells, and migrate into the basement membrane. The 
primitive heart primorida then fuse to form one double-layered tube 
consisting of an Inner and outer epithelia (the endocardium and 
myocardium, respectively) separated by a middle acellular basement 
membrane known as the cardiac jelly. 
The transformation of the heart from a simple tube to a four-
chambered structure containing valves involves a second epithelial-
mesenchyme transformation. That is, the ECT arIses from cells of the 
endocardial endothelium that de-adhere, convert into mesenchymal cells, 
and migrate into the cardiac jelly (the epithelial-mesenchymal 
transformation) (38, 41). NCAM is continuously expressed on all cells of the 
myocardium and endocardial endothelium; in contrast, N-cadherin is 
expressed only in the myocardium at this stage of heart development (40). 
Concomitantly with their de-adhesion, migrating ECT cells down-regulate 
their expression of NCAM (7, 45) as assayed immunohistochemically (7, 45, 
71). Later in development, the growing cushion tissue pads fuse in a manner 
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that subdivides the flow of blood through the heart into two channels. It is 
therefore likely that the regulation of NCAM expression or function plays a 
major role in mediating this sequence of de-adhesion and adhesion that occur 
during the epithelial-mesenchymal transformation and the fusion of cushion 
tissue pads. 
While cDNA sequence data have demonstrated the existence of NCAM 
molecules containing the MSD region, the presence of these inserts in 
particular NCAM polypeptides and their immunohistological distribution in 
the tissue have not been examined. This was due to the absence of specific 
antibody probe that can selectively identify the MSD peptide inserts found in 
NCAM subspecies. This thesis, therefore, emphasizes two specific aims. The 
first aim is to identify and characterize NCAM species containing the MSD at 
the level of protein. This requires production of an antibody specifically 
directed against the MSD sequence. The second aim is to study tissue 
distribution and subcellular localization of NCAM containing the MSD. This 
is to understand the significance and mechanism of MSD function among 
NCAM variants. As a research model, we have chosen chicken heart 
development and focused on tissue differentiation in the myocardium in 
particular. We found that NCAM expression including species containing 
the MSD undergoes dramatic changes while myofibrillogenesis occurs. The 
present studies suggest the potential function of MSD-containing NCAM. 
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MATERIALS AND METHODS 
Reagents 
Reagents were purchased from the following sources: Keyhole limpet 
hemocyanin (KLH), Calbiochem (San Diego, CA); N-succinimidyl 3-(2-pyridyl 
dithio) propionate (SPDP) and BCA protein assay kit, Pierce (Rockford, IL); 
reagents for gel electrophoresis and Western blotting, Bio-Rad Laboratories 
(Hercules, CA); leupeptin, Boehringer Mannheim Corp. (Indianapolis, IN); 
neuraminidase from Streptococcus sp. (catalog number 151738), ICN 
Biomedical Inc. (Costa Mesa, CA); DE 52, Whatman Lab Sales Inc. (Hillsboro, 
OR); CNBr, Aldrich Chemical Co. Inc. (Milwaukee, WI). All other reagents 
were obtained from Sigma Chemical Co. (St. Louis, MO) . 
Antibodies 
Anti-NCAM: NCAM from 14-day embryonic chicken brains, purified as 
described below or as previously described (32), was used to immunize rabbits. 
This antibody is frequently referred to as the pan NCAM antibody because it 
recognizes all forms of NCAM. 
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Anti-12AB and anti-12CD: Two peptides that together comprIse the MSD 
region in chicken NCAM (Prediger et al., 1988) were synthesized by the MUSC 
Protein Sequence Facility. Oligopeptide 12AB contains the sequence encoded 
byexons 12A and 12B (single letter code RIPHSPSAAAPTCLAE); oligopeptide 
12CD contains the sequence encoded by exons 12C and 12D 
(TTQPLP ASESTEPPKG) (Figure 3). Each peptide was synthesized with two 
additional cysteine residues at its C-terminal. In order to induce strong 
immunogenicity, each oligopeptide was conjugated with KLH prior to 
immunization. First, Cys residues were reduced using 100 mM dithithreitol 
(DTT) for 30 min, and the pep tides were desalted on G-25 Sephadex 
equilibrated in 0.1 M sodium phosphate/ 0.1 M sodium chloride (NaCI), pH 
7.5. KLH was desalted using this same buffer, then activated with SPDP at a 
molar ratio of 1: 2,500 for 1 hour, then desalted again. Finally, the reduced 
oligopeptides were incubated with the activated KLH at a 500:1 molar ratio for 
1 hour, then desalted. These oligopeptide-KLH conjugates were dialyzed 
against water, lyophilized, and resuspended in phosphate buffered saline 
(PBS). Subcutaneous inoculations into rabbits (50 J.Lg NCAM or 1 mg 
oligopeptide-KLH conjugates per rabbit per injection) and IgG purification 
from serum were performed by standard methods (71). 
Monoclonal antibodies 4d (specific for the ld form of NCAM) and V2E9 
and JG22 (each specific for the f31 integrin subunit) were obtained from the 
Developmental Studies Hybridoma Bank. Monoclonal antibody NCD-2 
13 
(specific for N-cadherin) was a gift from Dr. Jack Lilien, Clemson University, 
Clemson, SC. Monoclonal antibodies against vinculin and a-actinin 
(sarcomeric) were obtained from Sigma Chemical Co. [Product Numbers V-
9131 (clone hVIN-1) and A-7811 (clone EA-53) respectively]. 
Slot Blot 
This simple assay allows the determination of the ability of an antibody 
to interact with a native (non-denatured) antigen. The antigen is placed in a 
plastic slot and transferred onto a nitrocellulose membrane by gravity or a 
mild vacuum (Slot Blot kit, Bio-Rad). The membrane-bound antigen is then 
detected by Western blotting. The membrane is blocked in tris buffered saline 
(TBS) containing 3 % gelatin, incubated with a primary antibody in the 
presence of 1 % gelatin, incubated with a secondary antibody-alkaline 
phosphatase conjugate. Color development is performed in carbonate buffer, 
pH 9.8, using bromochloroindoyl phophate (BCIP) and nitroblue tetrazolium 
(NBT) substrates. The resulting color on a membrane is scanned using an 
Apple Macintosh computer and Adobe Photoshop software. The image 
information is then converted to numeric data using an Image Anaysis 
Program 1.4. 
ELISA (Enzyme-Linked Immunoabsorbent Assay) 
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The sensitivity of this assay allows us an accurate estimation of the 
specific interaction occurring between antibody and antigen. 96-\vell 
microtiter plates are coated with various soluble antigens for 1 hr. 
Nonspecific protein binding sites are blolcked with 30/0 bovine serum 
albumin (BSA) in phosphate buffered saline (PBS) for 2 hr. The primary 
antibody and then the secondary antibody, a HRP (horseradish peroxidase)-
conjugate, are applied for 1 hr each in PBS containing 1 % BSA. The color 
reaction IS performed uSIng substrates, 2, 2' -Azinobis (3-
ethylbenzoothiazoline-6-sulfonic acid) diammonium salt (ABTS) and 
hydrogen peroxide (H20 2), and is quantitated by measuring the optical density 
(OD) at 414 nm using a plate reader. 
Western Blot 
Samples were resolved by SDS-polyacrylamide gel electrophoresis 
(SDS-P AGE) under reducing conditions on minigels containing 6 0/0 
acrylamide except in the experiment on cyanogen bromide (CNBr) fragments 
of NCAM in which 12 % acrylamide was used and non-reducing conditions 
were used to enhance antigenicity. Proteins were transblotted to 
nitrocellulose using a semi-dry transfer method (Trans-Blot Semi-Dry 
Electrophoretic Transfer Cell, Bio-Rad). The nitrocellulose was blocked, 
incubated with primary antibodies, incubated with secondary antibodies (goat 
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anti-rabbit or anti-mouse IgGs conjugated to alkaline phosphatase), and color 
developed using BCIP and NBT as described as above (Reagents, Bio-Rad). 
Preparation of Membranes! NP40 Extraction! Neuraminidase Treatment! 
PIPLC Digestion 
Purified membranes were prepared from 14-day embryonic chicken 
brains and 14-day embryonic and adult chicken hearts. Brains in cold PBS 
containing protease inhibitors (N-ethylmaleimide, 10 mM; benzamidine, 5 
mM; leupeptin, 50 f.lg/ml; aprotinin, 2 J..lg/ml; phenylmethylsulfonylfluoride 
(PMSF), 2mM; pepstatin A, 5 f.lg/ml) were homogenized using a Braun-Sonic 
2000 U ultrasonic generator. Homogenates were overlayed on PBS containing 
42 % sucrose, then ultracentrifuged at 100,000 g for 30 min at 4 0 C. The 
membrane fraction which appeared above the 42 % sucrose was harvested, 
washed by dilution with cold PBS, and collected by centrifugation at 8 K rpm 
for 20 min in a JA10 rotor in a Beckman J2-HS High Speed Centrifuge. For 
heart membrane preparation, tissue was sonicated in ice-cold hypotonic 
buffer (200 mM sucrose/ 5 mM sodium phosphate, pH 7.5/ 1 mM (ethylene-
dioxy) diethylenedinitro tetraacetic acid, EGTA) in the presence of protease 
inhibitors. Low-speed centrifugation, 300 g for 10 min, separated the 
membranes from nuclei and large debris. Membranes in the supernatant 
were then collected by ultracentrifugation at 100,000 g for 30 min. 
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Preparation of Cell Membranes 
14D Chick Brains 
mb is hom!geniZed 
in PBS / protease inhibitors 
I 
macromolecular debris is removed 
by ultracentrifugation 
through a 42 % sucrose cushion 
(lOO,OOOg, 30 min, 4° C) 
mb in PBS }s pelleted 
(centrifugation, 8000 rpm, 20 min, 40 C) 
14D Chick Hearts 
I 
mb is homogenized 
in hypotonic BF / protease inhibitors 
macromolecular debris is pelleted, discarded 
(low speed centrifugation, 300g, 10 min, 4oC) 
I 
mb is pelleted 
(ultracentrifugation, 100,000g, 30 min, 40 C) 
ECM contaminants are washed with 0.1 M Tris base, 
mb is neutralized with 0.2 M phosphate, pH 6.3. 
Figure 4. Preparation of Cell Membranes from Embryonic Chicken Tissue. 
Embryonic day 14 chicken tissues, brain or heart, are isolated and 
homogenized. Cell membrane is fractionated from cytoplasmic contaminants 
by ultracentrifugation (see details in the Materials and Method section). 
Abbreviations: mb (membrane), BF (buffer), PBS (phosphate buffered saline), 
ECM (extracellular matrix) 
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Crude membranes were prepared from 4-day, 7-day, and 10-day 
embryonic chicken hearts and 5-day embryonic chicken ventricles and 
cushion tissue pads. Tissue in PBS was homogenized in the presence of 
protease inhibitors, then washed with PBS and harvested by two rounds of 
centrifugation (14,000 rpm, 3 min) in a microfuge (Figure 4). 
To prepare nonidet P-40 (NP40) extracts for Western blotting and 
peanut lectin chromatrography, membranes were pelleted in a microfuge 
(14,000 rpm, 3 min), resuspended in 10 volumes of 0.5 % NP40/ PBS, and the 
extracts clarified in the microfuge (14,000 rpm,S min). The protein content of 
NP40 extracts was quantitated using the BCA assay. 
To neuraminidase treat membranes, pelleted membranes were 
resuspended in 3 volumes of PBS containing 0.3 U / ml of neuraminidase, 
incubated for 1 hour at 37° C, then washed with PBS and harvested by 
centrifugation. To neuraminidase treat NP40 extracts, neuraminidase was 
added to NP40 extracts to a final 0.3 U / ml and incubated 1 hour, 37° C. 
To phosphotidylinositol-specific phospholipase C (PIPLC) digest 
membranes, pelletted membranes were resuspended in 3 volumes of PBS 
containing 0.02 U / ml of PIPLC (from Bacillus cereus, Sigma catalog number P 
8804), incubated for 30 min at 37° C, and the PIPLC-released molecules in the 
supernatant harvested by centrifugation in a microfuge (14,000 rpm, 3 min). 
The residual membrane pellet was NP40 extracted as described above. 
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Immunoprecipitation of NCAM Molecules Containing the MSD Region 
Purified membranes from 14-day embryonic chicken hearts (50 JlI 
packed volume) were resuspended in 0.5 ml PBS containing 1mg/ml anti-
12AB or anti-12CD immunoglobulin (IgG) and incubated for 1 hour at 4° C 
with agitation. Membranes were washed with PBS and harvested by two 
rounds of centrifugaton in a microfuge (14,000 rpm, 3 min). The membranes 
were extracted with NP40 as described above and antigen-antibody complexes 
were collected by incubation with 50 Jll of Protein A-Sepharose for 1 hour at 
4° C. The beads were then washed several times with 0.5 % NP40/ PBS. 
Bound NCAM was eluted by boiling the beads in SDS-P AGE sample buffer 
and Western blotted using the pan NCAM antibody as the primary antibody 
for detection. This procedure allowed immunoprecipitation experiments to 
be performed using anti-12AB and anti-12CD. Immunoprecipitation 
experiments performed with these antibodies in which the antibodies were 
added to proteins which had already been NP40 extracted gave uniformly 
negative results. 
Peanut Lectin Chromatography 
1.5 ml of NP40 extract from purified membranes from 14-day 
embryonic chicken hearts was incubated with 50 Jll of peanut lectin-agarose 
(Sigma catalog number L 2507) for 1 hour at 4 ° C with agitation. The beads 
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were then washed several times with 0.5 % NP40/ PBS and bound proteins 
were eluted with 0.5 ml of 0.5 % NP40/ PBS/ 0.1 M galactose. 
Purification of NCAM! CNBr Digestion 
Packed brain or heart membranes were resuspended in 10 volumes of 
0.1 M Tris base to elute weakly attached proteins. Membranes were collected 
by ultracentrifugation and extracted in 10 volumes of 0.5 % NP40/ 0.2 M 
sodium phosphate, pH 6.3 containing protease inhibitors. Extracts were 
clarified by ultracentrifugation and applied to DE 52 equilibriated in 0.5 % NP-
40/ 0.2 M sodium phosphate, pH 6.3 (10 ml of extract per ml of beads). The 
column was washed with 0.2 M sodium phosphate, pH 6.3 until no NP40 
could be detected in the eluate. Contaminants were then eluted with 1 M 
NaCI/ 20 mM sodium phosphate, pH 6.5. The column was then washed with 
25 mM octylthioglucopyranoside (OTG)/ 20 mM sodium phosphate, pH 6.5. 
Finally, NCAM was eluted from the DES2 using 0.55 M NaCI/ 25 mM OTG/ 
20 mM sodium phosphate, pH 6.5. The eluate was dialyzed versus water and 
lyophilized. NCAM was further purified by HPLC gel filtration on a 
TosoHaas G4000SW column equilibrated with 25 mM OTG/20 mM sodium 
phosphate, pH 6.S (Figure 5). This procedure yielded brain NCAM that was 
essentially 100 % pure as evaluated by SDS-P AGE and heart NCAM that was 
about 30 % pure. 
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Purification of NCAM 
Cell mb is prepared 
l 
Mb Proteins Extracted by 0.5 % NP40/ 0.2 M phosphate, pH 6.5 
l 
DE 52 Ion Exchanger 
Extract is poured into the column, 
NP40 is washed out, 
Contaminants are washed with 1 M NaCI, 
Column is re-equilibrated with 25 mM OTG, 
NCAM is finally eluted with 0.55 M NaCI/25 mM OTG. 
~ 
Eluate is dialyzed & lyophilized 
~ 
HPLC Gel Filtration G4000SW 
Figure 5. Purification of NCAM Molecules from Tissue Extract. 
Proteins are extracted from the cell membrane fraction by NP40 (see 
Figure 4). Cell membrane extract is subjected to a DEAE anion exchange 
chromatography where the NCAM is eluted by a high salt buffer containing a 
detergent, GTG. NCAM is further purified by high pressure liquid 
chromatography using a G4000SW column. The purity of NCAM molecules 
is analyzed by gel electrophoresis and western blotting. Abbreviations: mb 
(membrane), NP40 (nonidet P-40), OTG (otyl thioglucopyranoside), HPLC 
(high pressue liquid chromatography). 
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Purified NCAM was dialyzed versus water, adjusted to a final 70 0/0 
formic acid, and treated with a large excess of CNBr under N 2 overnight, then 
dried in a Speed-Vac. This material was then dissolved in a small volume of 
25 mM OTG / PBS and neuraminidase treated as described above. 
Imm unohistochemistry 
Hamburger-Hamilton (25) stage 18 chicken embryos were briefly rinsed 
in PBS and placed in plastic molds with Tissue-Tek compound media (ICN). 
Samples were quick frozen using liquid nitrogen. Five micron frozen 
sections were cut and mounted on poly-L-Iysine-coated slide glasses. After 
rinsing off the embedding medium with distilled water and PBS, the sections 
were incubated at room temperature with 10 % normal goat serum /PBS for 
30 minutes to block non-specific binding. Sections were incubated with 
primary antibodies (25 J.Lg/ml for rabbit antibodies, 10 J.Lg/ml for monoclonal 
antibodies except for anti-vinculin and anti-u-actinin which were used at 
1:400 and 1:800 dilutions respectively as per the vendor's instructions) in 1 0/0 
BSA/PBS in a humid chamber at 4 °C for 4-16 hours, then rinsed with 1 0/0 
BSA/PBS. Appropriate fluorescein conjugated secondary antibodies [10 
J.Lg/ml of goat anti-rabbit IgG or goat anti-mouse IgG (Organon Teknika Corp., 
Durham/ NC) in 1 % BSA)PBSJ were applied for one hOUT"" foJJowed by rjnsjng 
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and mounting in 90% glycerol, 0.2 M n-propyl gallate (22). Stained sections 
were examined by epifluorescent illumination using a Zeiss Axioscope. 
Two experiments were performed to verify that the only molecules 
recognized by anti-12CD are NCAM molecules containing the peptide 
sequence used as immunogen. In one, the diluted antibody (25 Jlg/ml) was 
pre-absorbed by mixing with 1.25 Jlg/ml of the immunogenic peptide for 30 
minutes at room temperature, followed by clarification at 13,000 g. In the 
second, tissue sections were preincubated with the pan NCAM antibody (25 
Jlg/ml) for 4 hours prior to addition of anti-12CD (25 f.lg/ml). Both treatments 
completely blocked anti-12CD staining. 
To examine the distribution of anti-12CD staining in cultured cells, 
cells were released from stage 18 hearts as described by Krug et al. (38) and 
depleted of fibroblasts as described by Lau (39). This method selectively 
removes the fibroblastic cells which grow rapidly in a monolayer culture than 
myocytes. Ventricle portions of hearts are trypsinized to disperse and the cell 
suspension is allowed to settle for 2 hours in a culture dish. Because 
fibroblasts adhere to the dish ahead within this period, the media mainly 
composed of myocytes is then transferred to a new culture plate. The 
enriched cardiomyocytes were plated on slides coated using a 20 Jlg/ml 
solution of fibronectin (New York Blood Center, New York, NY) and 
incubated for 3-7 days in the 'complete M199 medium' of Krug et al. (38). 
Cells were fixed with cold methanol (10 min, -20 0 C), then rinsed briefly with 
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50 % methanol/50 % PBS followed by a PBS rinse. Cells were stained as 
described above and examined by confocal microscopy. 
Confocal Microscopy 
As described above, lO-J.!m frozen sections were prepared and stained 
with anti-12CD as the primary antibody and fluorescein isothiocyanate (FITC)-
conjugated goat anti-rabbit IgG as the secondary antibody. The sections were 
then double stained by further incubation with either monoclonal anti-a-
actinin (sarcomeric) followed by tetramethylrhodamine isomer R (TRITC)-
conjugated goat anti-mouse IgG or the pan NCAM antibody followed by 
TRITC-conjugated goat anti-rabbit IgG. Stained sections were examined by 
confocal microscopy using a Bio-Rad MRC-IOOO equipped with a Zeiss 
Axioscope. The confocal iris was set at the smallest value to obtain the 
thinnest possible optical sections « 0.25 J.!m). 
24 
RESULTS 
Antibodies Specific to the MSD Region of NCAM 
The whole NCAM gene is composed of 19 major exons. According to 
Nothern blot and cDNA sequence data, a subset of NCAM contains a peptide 
sequence that is encoded by four small alternatively spliced exons, 12A, B, C, 
and D (Figure 2). The small four exons are located between exons 12 and 13 of 
the NCAM gene. This portion of the molecule was originally (15) named the 
muscle specific domain (MSD); this nomenclature will be used here. The 
MSD found in the chicken heart consists of 31 amino acid. The localization of 
MSD is predicted to be between two fibronectin homologous repeats in the 
extracellular region of NCAM protein. The predicted localization and the 
deduced amino acid sequence of this region of NCAM are shown in Figure 2. 
Since our initial goal was to identify the subset of heart NCAM that 
contains the MSD insert in its protein structure, it was necessary to produce 
an antibody specific to this MSD sequence. Using synthetic oligopeptides, two 
polyclonal antibodies were prepared against the MSD region of NCAM; one 
(anti-12AB) is against the polypeptide sequence encoded by exons 12A and 
12B, the second (anti-12CD) against the polypeptide encoded byexons 12C and 




































Figure 6. Specificity of Anti-MSD Antibodies against MSD Sequences. 
MSD oligopeptides were challenged with anti-MSD antibodies in an 
ELISA. A 96-well microtiter plate was coated with 20 ng of 12AB or 12CD 
oligopeptide, incubated with the anti-MSD (anti-12AB or anti-12CD) antibody, 
then incubated with the secondary antibody-horseradish peroxidase 
conjugates. The subsequent color reaction measured at absorbance 414 nm is 
indicated at the y-axis with arbituary numbers. The results show that within 
the MSD sequence each anti-MSD recognizes an independent sequences; anti-








. TIle rest-tlts show that 
within MSD 
Expression of the MSD Region in NCAM 
we 
We have the 
t11e a 
witllot-lt NCAM was 
as 
row or 
NCAM, which are 
\vitll an While 
anti-NCAM anti-12AB 
Br Ht Br Ht 
Figure 7. Anti-MSD Recognizes NCAM from Heart Tissue 
but Not from Brain. 
anti-12CD 
Br Ht 
The ability of anti-MSD to recognize intact NCAM molecules was 
examined by slot blotting. Matching slots in the left and right row contain 
equal amounts of purified brain and heart NCAM, respectively. From the 
top, slots contain 10 ng (top), 50 ng (middle), or 250 ng (bottom) of purified 
NCAM. The antigen immobilized in the slot was challenged with various 
anti-NCAM antibodies, then the result is shown by secondary antibody-
mediated alkaline phosphatase color reaction. NCAM isolated either from 
brain or heart tissue is recognized by a pan anti-NCAM antibody. The anti-
12AB or anti-12CD exclusively recognizes the NCAM species that are present 
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Figure 8. Specificity of Antibodies against the MSD Region of NCAM. 
As described in the Methods, NP40 extracts of 14-day embryonic 
chicken heart and brain membranes were neuraminidase treated, then 
Western blotted using antibodies prepared against the indicated antigens as 
the primary antibodies for detection. Brain or heart extract is loaded to 
contain equal amount of NCAM to each lane; lanes containing heart extract 
(Ht) were loaded with 5 ~g of protein for detection with the pan NCAM 
antibody and 15 ~g of protein for detection with anti-12AB or anti-12CD, also, 
lanes containing brain extract (Br) were loaded with 1 ~g of protein for 
detection with the pan NCAM antibody and 3 ~g for detection with anti-12AB 
or anti-12CD. This 5:1 ratio of heart extract to brain extract results in similar 
levels of total NCAM detected with the pan NCAM antibody. The four forms 
of heart NCAM recognized by the pan NCAM antibody (ISS, 145, 125, and 120 
kD) and the two forms of heart NCAM recognized by anti-12AB and anti-
12CD (155 and 125 kD) are indicated. An extra band seen in the brain extract 
detected by anti-NCAM is the proteolytic fragment of NCAM produced 
during tissue preparation. The migration of standard proteins is indicated by 






Splice in Heart Tissue 
are 
a 
NCAM 1.2AB 12CD 
185 kD _______ 
180 kD .,.' 
Ht Ht Ht 
180kD : Detection 
B·r Ht 
Figure 9. Forms of NCAM in 7-day Embryonic Heart Tissue. 
As described in the Methods, NP40 extracts of membranes were 
neuraminidase treated, then Western blotted using antibodies specific for the 
indicated antigens as the primary antibodies for detection (180 kD indicates 
the use of monoclonal antibody 4d specific for the ld form of NCAM). Lanes 
containing 7-day embryonic heart extract (Ht) were loaded with 5 Ilg of 
protein for detection with the pan NCAM antibody or 4d and with 15 Jlg of 
protein for detection with anti-12AB or anti-12CD. The lane containing 14-
day embryonic brain extract (Br) was loaded with 1 Ilg of protein. The 185 and 
180 kD forms of heart NCAM recognized by a 4d (anti-180) antibody are 
indicated. 
31 
molecular weight of about 180 kD and had previously been demonstrated 
conclusively only in neural tissues. 
Extract of 7-day embryonic hearts was analyzed for NCAM expressIon 
(Figure 9). Including the three basic forms of heart NCAM (the ld, sd, and ssd) 
that have been previously predicted by the molecular biology data, we detect 
total six different structural variants of NCAM from the day 7 embryonic 
heart. That is, the 185 and 180 kD forms are newly detected in addition to the 
four species (155, 145, 125, and 120 kD) observed in 14-day heart extracts 
(compare to Figure 8). The 185 kD, 145 kD, and 125 kD species all contain the 
MSD region which is detected by anti-12AB and anti-12CD (Figure 9). 
To determine whether the 185 and 180 kD forms of NCAM observed in 
7-day embryonic heart are authentic ld NCAM, extracts were Western blotted 
using monoclonal antibody 4d specific for this form of NCAM (76) (Figure 9). 
Both the 185 and 180 kD forms of heart NCAM, as well as a form of brain 
NCAM of similar molecular mass (known as the 180 kD), were recognized by 
this anti-180 antibody. These results indicate that two forms of ld NCAM (185 
and 180 kD) are present in heart extracts, and that one (185 kD) of those ld 
forms also contains the MSD region. 
Transmembrane' versus GPI-linked Forms of NCAM 
To determine which of the forms of NCAM we observe are GPI-linked 
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Figure 10. Transmembrane and GPI-linked Forms of NCAM. 
As described in the Methods, 14-dayembryonic heart membranes were 
neuraminidase treated, treated with PIPLC to release GPI-linked proteins, and 
the residual membranes were extracted with NP40. NP40 extracts (5 f.lg for 
detection with the pan NCAM antibody; 15 f.lg for detection with anti-12CD) 
and PIPLC-released material (from equivalent amounts of membranes as the 
NP40 extracts) were Western blotted using antibodies prepared against the 
indicated antigens as the primary antigens for detection. The four forms 
(recognized by the pan NCAM antibody) of heart NCAM in NP40 extracts 
(ISS, 145, 125, and 120 kD) and the two PIPLC-releasable forms of heart NCAM 
(125 and 120 kD) are indicated. 
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NCAM Splice Variants in Brain or Heart Tissue 
mode ofmb Brain Heart 
attachment 
Id 
185 kD (MSD+, a-linked Sugar+ ?) 
180kD 180kD 
sd 
155kD (MSD+, a-linked Sugar+) 
140kD 145kD 
125kD (MSD+, a-linked Sugar+) 
ssd 120kD 120kD 
Table 1. Comparison of the Forms of NCAM in Brain and Heart Tissues. 
NCAM consists of three structural forms defined by their modes of 
membrane attachment. In heart, these ld, sd, or ssd forms are expressed with 
or without the MSD sequence, whereas no MSD is expressed in brain NCAM. 
A notable feature of the MSD is that it contains serine and threonine 
sequences which are acceptor sites for O-linked oligosaccharides as 
demonstrated by peanut lectin binding specificity (Figure 13). We assume the 
185 kD form also binds to the peanut lectin as the other MSD containing 
NCAM species (145 kD and 125 kD) do. 
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were treated with PIPLC to release the CPI-linked forms. NP-40 extracts of the 
residual membranes (Figure 10, A) or the PIPLC-released material (Figure 10, 
B) were then Western blotted with either anti-NCAM or anti-12CD. Only the 
125 and 120 kD forms of NCAM were released by PIPLC, and of these, only the 
125 kD form was recognized byanti-12CD. As in Figure 8, the ISS, 145, 125, 
and 120 kD forms of NCAM were present in the residual membranes, of 
which only the 155 and 125 kD forms were recognized byanti-12CD. Thus, it 
appears that the 185 and 180 kD forms of NCAM are ld, the 155 and 145 kD 
forms are sd, and the 125 and 120 kD forms are ssd. In each pair, there is a 
higher molecular weight species containing the MSD region and a lower 
molecular weight species lacking the MSD region (summarized in Table 1). 
The MSD Region Does Not Show Heterogeneity In Molecular Weight 
PCR amplification studies of rat heart cDNAs suggested that alternative 
splicing occurs among exons 12A-D which should lead to multiple forms of 
NCAM with MSD regions of different sizes (Reyes et al., 1991). In contrast, 
our results show no evidence for size heterogeneity in the MSD regions of ld, 
sd, or ssd NCAM from either 7-dayor 14-day embryonic hearts (Figures 8, 9, 
and 10). To evaluate whether we do not observe size heterogeneity because 
the differences in the sizes of the variants are too small compared to the size 
of the intact NCAM molecule, CNBr fragments of heart NCAM were 
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Figure 11. MSD region in CNBr digests of NCAM. 
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As described in the Methods, NCAM was purified from 14-day 
embryonic brain and heart membranes, digested with CNBr, neuraminidase 
treated, and Western blotted using antibodies prepared against the indicated 
antigens as the primary antibodies for detection. Lanes containing brain 
NCAM CNBr fragments (Br) were loaded with 10 Jlg of protein for detection 
with the pan NCAM antibody and 30 Jlg of protein for detection with anti-
12AB or anti-12CD; lanes containing heart NCAM CNBr fragments (Ht) were 
loaded with 30 Jlg of protein for detection with the pan NCAM antibody and 
90 Jlg of protein for detection with anti-12AB or anti-12CD. This ratio of brain 
and heart NCAM CNBr fragments was chosen to provide similar levels of 
signal using the pan NCAM antibody for detection. The migration of 
standard proteins is indicated by their Mr x 10-3• 
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(Figure 11). As expected from the localization of the MSD regIon within 
NCAM (Dickson et al., 1987), anti-12AB and anti-12CD recognized a single 
CNBr fragment of about 45 kO. No size heterogeneity in the MSD region was 
seen even in these smalle.r CNBr digests. In control experiments, no CNBr 
fragments of brain NCAM were recognized by either anti-12AB or anti-12CD, 
even though the profiles of CNBr fragments of brain and heart NCAM 
recognized by anti-NCAM were similar. These results indicate that, at the 
protein level, only one form of the MSD region can be detected in our 
extracts, presumably that encoded by mRNAs containing the transcripts from 
all of exons 12A, 12B, 12C, and 120. 
Polysialic Acid on NCAM Inhibits 
the Anti-MSD Accessibility to the Molecule 
NCAM molecules bear unIque, maSSIve polysialic acid-containing 
oligosaccharide(s) in a close proximity to the MSO region (9) (Figure 1). To 
determine whether this structure interferes with the ability of anti-MSD 
region antibodies to bind to the molecule, the ability of anti-12AB and anti-
12CD to recognize NCAM molecules before and after neuraminidase 
treatment was compared (Figure 12). Whereas polysialic acid does not 
interfere with the ability of anti-NCAM to recognize NCAM, anti-12AB and 
anti-12CD do not recognize NCAM in Western blots (Figure 12, A) or by 
immunoprecipitation (Figure 12, B) unless the polysialic acid is first removed 
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Figure 12. Effect of Polysialic Acid on the Recognition of NCAM by Anti-
12AB and Anti-12CD. 
A) Western blots. As described in the Methods, NP40 extracts of 14-day 
embryonic heart membranes (15 ~g aliquots) either without (-) or with (+) 
neuraminidase treatment were Western blotted using antibodies against the 
indicated antigens as the primary antibodies for detection. B) 
Immunoprecipitation. As described in the Methods, NCAM from 14-day 
embryonic heart plasma membranes, either without (-) or with (+) 
neuraminidase treatment, was immunoprecipitated using anti-12CD IgG. 
This material was Western blotted using the pan NCAM antibody as the 
primary antibody for detection. Similar results were obtained in 
immunoprecipitation experiments using anti-12AB IgG (data not shown). 
The heavy band. near the bottom of both lanes represents IgG heavy chain. 
The migration of the 155 and 125 kD forms of NCAM containing the MSD 
region is shown in both A and B. 
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from the molecule. In contrast to the Western blot, anti-12CD does recognize 
NCAM equally well before and after neuraminidase treatment In 
immunohistochemical assays (Figure 16, 17, 18, 19, 20, and 22). 
Forms of NCAM Containing the MSD Also Bind to Peanut Lectin 
NCAM from a skeletal muscle cell line consists of a 155 kD 
transmembrane form that contains the MSD region and binds to peanut 
lectin as well as a 125 kD GPI-linked form that does not contain the MSD 
region and does not bind to peanut lectin (75). In order to characterize the 
peanut lectin binding of heart NCAM, NP40 extracts of plasma membranes 
from 14-day embryonic heart tissue were fractionated on immobilized peanut 
lectin; the forms of NCAM in the total and eluate were then detected by 
Western blotting with anti-NCAM, anti-12AB and 12CD (Figure 13). NCAM 
molecules bind to peanut lectin only after neuraminidase treatment; even 
then, only the two polypeptides (155 and 125 kD) recognized byanti-12AB and 
anti-12CD bind to peanut lectin. These results are consistent with the facts 
that peanut-lectin binding oligosaccharides are believed to be O-linked and 
that the MSD region contains two putative acceptor sites composed of Ser or 
Thr residues for O-glycosylation. 
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Figure 13. Binding of NCAM to Immobilized Peanut Lectin. 
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As described in the Methods, NP40 extracts of 14-day embryonic heart 
membranes, either untreated (-) or treated (+) with neuraminindase, were 
incubated with peanut lectin-agarose. Aliquots of the total extract (T) and the 
0.1 M galactose eluate (E) were Western blotted using antibodies against the 
indicated antigens as ,the primary antibodies for detection. Lanes containing 
total extract were loaded with 5 Ilg of protein for detection with the pan 
NCAM antibody and with 15 Ilg of protein for detection with anti-12AB or . 
anti-12CD; lanes containing the galactose eluate were loaded with the 
material purified from 20 Ilg of extract for detection with the pan NCAM 
antibody and with the material purified from 60 }.lg of extract for detection 
with anti-12AB or anti-12CD. The migration of the 155 and 125 kD forms of 
NCAM that are specifically precipitated by immobilized peanut lectin and are 
specifically recognized by anti-MSD region antibodies are indicated. 
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The temporal expressIon pattern of NCAM specIes was examined 
during the course of heart development. The forms of NCAM present in 
extracts from 4-day, 7-day, 10-day, and 14-day embryonic heart tissue and adult 
heart tissue were compared by Western blotting (Figure 14). Dramatic shifts 
were observed in the expression of ld, sd, and ssd NCAM as well as in the 
proportions of each of these forms containing the MSD region. ld NCAM was 
present at 4 days, peaked at 7 days, was still present at 10 days, but absent 
thereafter. This observation supports our idea that the ld NCAM is actually 
present in the heart (Figure 9) and not in the innervation of the heart, 
because a different time course would have been expected for a molecule 
associated with the innervation of the heart (peaking later and more 
persistent) (77). The sd form of NCAM is expressed in a similar time course 
as ld, while the ssd is expressed later in development and is essentially the 
only form observed in adult tissue. 
The ratio of MSD positive to MSD negative forms of NCAM varIes 
during development. For ld, sd, and ssd NCAM the percentage of the 
molecules containing the MSD region always increases during development 
(Figure 14). For example, in 7-day tissue the MSD-positive 185 and 155 kD 
forms of ld and sd NCAM are present in similar concentrations to the MSD-
negative 180 and 145 kD forms of ld and sd. By 10 days, these MSD-positive 
forms are clearly present at higher concentrations than the corresponding 
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Figure 14. Forms of NCAM Present in the Developing Heart. 
As described in the Methods, 5 ~g aliquots of NP40 extracts of 
membranes from 4-day (4), 7-day (7), 10-day (10), and 14-day (14) embryonic 
heart tissue, and from adult (A) heart tissue were neuraminidase treated, 
then Western blotted using the pan NCAM antibody as the primary antibody 
for detection. The migrations of the 185, 180, ,155, 145, 125, and 120 kD forms 
of NCAM are indicated; those containing the MSD region (185, 155, and 125 
kD) are in bold. The identity of these forms of NCAM was confirmed in 
parallel experiments using anti-12AB and anti-12CD for detection (data not 
shown). The migration of standard proteins is indicated by their Mr x 10-3• 
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Developmental Changes in Expression of theNCAM Splice Variants 
mb MW day 4 day 7 day 10 day 14 adult 
attachment 
185 kD (MSD+) + ++ ++ 
Id 180kD + + + 
155 kD (MSD+) ++++ ++++ ++++ ++ 
sd 145kD +++ ++++ ++ + 
125 kD (MSD+) + ++ ++ ++++ ++++++++ 
ssd 120kD + + + + 
L...........~ __ ~ ~ i _,,~~~~~~~,.s_,~ __ ~ __ ~ < ".NV""~_~~~ 
Table 2. Developmental Changes in NCAM Species. 
Chicken hearts are isolated from the different stages of development and extracted with NP40. When 
similar amounts of tissue extract are loaded to the gel, we observe that the ratios of NCAM species changes 
dramatically according to heart development (Figure 14). Whereas the the membrane bound forms of NCAM 
(ld. sd) are abundantly expressed at earlier stages, the PIPLC-linked forms (ssd) are dominant at later stages. In 
adult, most NCAM are expressed as the PIPLC-releasable form. At any time of development, the MSD 
containing NCAM subspecies compose a bigger population than the ones lacking it. Also, the percentage of 
the MSD-positive NCAM increases as development proceeds. 
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NCAM is present in 7-day tissue but below detection thereafter, while the 125 
kD MSD-positive form of ssd NCAM continues at high concentration 
throughout development (summarized in Table 2). 
Spatial Variation in the Expression of NCAM Species 
In order to understand the role of NCAM speCIes during heart 
morphogenesis, we have carefully examined the tissue distribution and 
subcellular localization of various NCAM forms. Spatial variations in the 
expression of forms of NCAM are readily detected in tissue extract prepared 
from different compartments of heart. Ventricular tissue (primarily 
myocardium) from 5-dayembryos contains a similar set of forms of NCAM 
(Figure 15) to that observed in the 4-day or 7-day heart (Figure 14). In contrast, 
atrioventricular cushion tissue from 5-day embryos contains primarily one 
form of NCAM, the MSD-negative form of sd. It contains much less ld, ssd, 
or even the MSD-positive form of sd NCAM than does the ventricular extract 
from the same stage embryos. Moreover, the small amount of MSD-positive 
sd present may be due to myocardial contamination of the cushion tissue 
given that cultured endocardial or mesenchymal cells contain only one form 
of NCAM, MSD-negative sd (Mironov, V., R. R. Markwald, and S. Hoffman, 
unpublished observations). Thus, the percentage of MSD-positive NCAM in 
heart tissue can vary from almost a to 100 % depending on the stage of 
development and region of the heart. 
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Figure 15. Endocardial Cushion Tissue is Deficient in GPI-linked and MSD 
Region-containing Forms of NCAM. 
Ventricles (V) and cushion tissue (CT) pads were dissected from five-
day chicken embryos. As described in the Methods,S J.1g aliquots of NP40 
extracts of membranes were neuraminidase treated, then Western blotted 
using the pan NCAM antibody as the primary antibody for detection. Small 
arrows on the left indicate the forms of NCAM (ISS, 125, and 120 kD) present 
at relatively high levels in the ventricle and low levels in cushion tissue; the 
large arrow on the right indicates the form of N-CAM (145 kD) present at 
relatively high levels in both samples. 
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Figure 16. Anti-12CD immunostaining of the Stage 18 Chicken Heart. 
Anti-12CD immunostaining was detected in the myocardium (M), 
whereas little staining was revealed in either endocardium (E) or in cushion 
mesenchyme (CM). Scale bar = 100 J..lm. 
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In order to determine the distribution at the immunohistochemical 
level of NCAM molecules containing the MSD region, sections of stage 18 
embryonic heart tissue were stained using anti-12CD (Figure 16). Since anti-
12AB was not useful in immunohistochemical studies, detection of the MSD 
in tissues was mainly dependent on using anti-12CD. As predicted from the 
results of Figure 14, the myocardium was stained with anti-12CD, while little 
or no staining was seen in the endocardium or endocardial cushion tissue. 
When the myocardial portion of these sections was observed at high 
magnification, a striking subcellular distribution of NCAM molecules 
containing the MSD region was observed; staining with anti-12CD appeared 
to coincide with the position of Z discs (Figure 17). This staining was specific; 
no staining was observed if the antibody was pre-incubated with the peptide 
used to produce anti-12CD (Figure 17, b) and no staining was observed with 
non-immune IgG (Figure 17, f). Although anti-NCAM antibodies did stain 
the surface of myocardial cells, they did not highlight Z discs (Figure 17, c). 
Other adhesion molecules, N-cadherin and Bl integrin, have previously 
been shown to be associated with Z discs later in development (29, 37, 68). We 
examined the expression of these proteins in stage 18 myocardium; while 
both molecules were present, neither N-cadherin (Figure 17, d) nor Bl 
integrin (Figure 17, e) colocalized with Z discs. Therefore, at this early stage in 
development, NCAM molecules containing the MSD region appear to 
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Figure 17. Comparative Immunostaining of Different Adhesion Molecules in 
the Stage 18 Chicken Heart Myocardium. 
a) High magnification photomicrograph depicts a striking subcellular 
distribution of anti-12CD staining (arrowheads) that coincides with the 
position of Z discs. b) A section adjacent to that shown in a) in which anti-
12CD was pre-absorbed with the immunogenic peptide as described in the 
Methods. Note that this treatment prevented the immunostaining seen in a). 
c) Immunostaining with the pan NCAM antibody was localized at the 
periphery of the myocardial cells. d) Anti-N-cadherin (NCD-2) 
immunostaining was found in a punctate pattern at the periphery of the 
myocardial cells. e) Anti-pI integrin (V2E9) immunostaining labeled the cell 
periphery. Similar results were obtained with anti-pI integrin antibody JG22. 
f) No staining was observed with non-immune rabbit IgG. Scale bar = 10 fl,m. 
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Figure 18. Confocal Microscopic Observation of Stage 18 Chicken Heart Doubly Stained with 
Anti-12CD and Anti-a-Actinin (sarcomeric) or Anti-12CD and Anti-NCAM. 
Double immunostaining routinely reveals a coincidence between anti-12CD (arrowheads 
in a) and a-actinin (arrowheads in b) staining in association with Z discs. Occasionally anti-a-
actinin staining is observed in the absence of anti-12CD staining (compare brackets in a and b). In 
contrast, there is only limited overlap between anti-12CD staining (c) and staining with the pan 
NCAM antibody (d). Cells in which the plane of focus captured the cell surface (regions between 
broken lines) showed almost uniform staining with the pan NCAM antibody (d) whereas anti-
12CD staining appeared in the characteristic pattern (c). Cells cut in equatorial section (asterisks 
inside) showed almost uniform circumferential staining with the pan NCAM antibody (d) and 
frequently show periodic circumferential staining with anti-12CD (c). Scale bar = 10 Jlm. 
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colocalize with Z discs, while N-cadherin, B1 integrin, and NCAM molecules 
lacking the MSD region do not exhibit this specific association. 
Confocal microscopy was used to confirm the localization of Z discs 
and forms of NCAM. When tissue sections were double-labeled using anti-
12CD and anti-u-actinin (an actin binding protein which is a marker for Z 
discs), an almost complete coincidence between the two signals was observed 
(compare Figures 18, a and b). In two regions (indicated by brackets), periodic 
anti-u-actinin staining was observed, but no staining with anti-12CD. These 
observations suggest that most Z discs in these cells are located close to the 
cell surface in the same confocal section (thickness is about 2 Jlm) as the MSD 
region-containing NCAM on the cell surface. Only the occasional set of Z 
discs is located either deeper in the cell, or is not associated with NCAM 
molecules containing the MSD region. 
When tissue sections were double-labeled using anti-12CD and the pan 
NCAM antibody, cells in which the plane of focus captured the cell surface 
showed almost uniform staining with the pan NCAM antibody, whereas 
anti-12CD staining appeared in the characteristic striped pattern (compare 
Figures 18, c and d, regions between broken lines). Only at scattered sites did 
the pan-NCAM antibody show any hint of highlighting NCAM molecules 
associated with Z discs. Similarly, cells in which the plane of focus cut an 
equatorial section (Figures 18, c and d, asterisks inside) showed 
circumferential staining which was relatively uniform with the pan NCAM 
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antibody and which was frequently periodic with anti-12CD. These results 
strongly suggest that NCAM molecules containing the MSD region are 
colocalized with Z discs while NCAM molecules lacking the MSD are 
uniformly distributed over the entire cell surface. 
Despite the fact that the anti-12CD antibody recognizes only NCAM in 
Western blotting experiments, we were concerned that it might recognize an 
additional protein in immunohistochemical studies. To rule out this 
possibility, tissue sections were sequentially incubated with the pan NCAM 
antibody and anti-12CD antibodies. This pretreatment with the pan NCAM 
antibody totally blocked anti-12CD staining (data not shown) indicating that 
the pan NCAM antibody and anti-12CD recognize the same protein, I.e. 
NCAM, and that anti-12CD does not recognize non-NCAM epitope. 
Structures known as 'costameres' have been identified by Pardo et al. 
(1983). A costamere is defined as a structure where the cell surface proteins 
are linked to subcelluar Z discs by a vinculin-containing structure. When we 
examined the distribution of vinculin in tissue sections from stage 18 
myocardium, however, the staining patterns observed did not coincide with 
the patterns obtained with anti-12CD or anti-u-actinin (Figure 18). Additional 
data (Figure 22) indicates that the association of vinculin with Z discs 
(costamere assembly) has not yet occurred at stage 18. 
Subcellular Localization of NCAM Splice Variants 
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in Cultured Carodiomyocytes 
Subcellular distribution of MSD containing NCAM specIes was also 
examined in stage 18 cultured cardiomyocytes. We have established a 
primary culture system that consists of over 90 % homogenous cardiomyocyte 
cells (see the Materials and Methods section). Dispersed myocytes show 
primitive muscle contraction upon attachment to the culture dish. After one 
or two days in culture/ myocytes organize their arrays of intracellular 
myofibrils (shown in Figure 19). As the culture proceeds/ cells form a web-
like monolayer between adjacent cells via extended myopodia. Muscle 
contraction is regular/ rhythmic/ and coordinated at this stage of culture/ 
which indicates completion of myofiber assembly in the cell. This in vitro 
property of myofiber disassembly-and-reassembly in culture much resembles 
the in vivo embryological myofibriUogenesis that occurs during mucle tissue 
differentiation (58). 
When NCAM was examined in cultured stage 18 myocardial cells/ 
anti-12CD staining was in register with Z discs (Figure 19/ a). Similar 
localization is also observed in VIVO/ in cardiomyocyte tissue of the 
developing heart (Figure 17 and 18); the double immunostaining result 
shows that the MSD-containing NCAM found at Z-discs are colocalized with 
a-sarcomeric actinin (compare Figure 18/ a and b). The 12CD staining pattern 
also depicts the rib-lik~ stripes at the cell surface of cultured cardiomyocytes. 
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Figure 19. Confocal Microscopic Observation of the Cultured Stage 18 
Myocardial Cells. 
Cells stained either with (a) anti-12CD or (b) a-(sarcomeric) actinin 
antibody show a similar immunohistochemical Z-line pattern. The fact that 
the MSD+ NCAM are localized at Z-discs in both single cell and in cells 
involved in cell-cell contact suggests the possibility of involvement of this 
NCAM in cell-ECM interactions rather than in cell-cell interactions. 
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Figure 20. Immunohistochemistry of the Cultured Cardiomyocyte. 
Myocardial cells were isolated from the stage 18 embryonic chicken 
heart. Cells were cultured, fixed, and stained by an anti-12CD. A highly 
magnified confocal microscopic image shows that the antibody precisely 
depicts arrays of Z-disc actin stripes at the cell surface. The rib-like stripes 
with a 2 J..lm distance detected by the anti-12CD is also typical of cytoplasmic Z 
disc actin bands. Size bar = 2 J..lm. 
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Figure 21. Composition and Alignment of Myofibers in Muscle Tissue. 
The upper figure illustrates a basic structure of skeletal muscle, which 
is shown as an actual electron microscopic image in the lower picture. 
Muscle is mainly composed of two myofiber types, actin (thin line) and 
myosin (thick line). Muscle contraction is achieved by the sliding motion of 
actin filaments into myosin, which results in the shortening of inter-actin 
distance. The Z-line represents the actin backbone which supports and 
maintains the movement of myofilaments. 
Figure source: L. Stryer, 1988. Biochemistry, 3rd ed. 
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When this pattern was further observed at a higher magnification, each stripe 
appears to coincide with the Z-discs that closely underlie the cell membrane. 
In addition, the inter Z-disc distance that is typically about 2 Jlm in the mature 
myofiber (23) precisely matches the distance between MSD-containing NCAM 
stripes (Figure 20). The typical structure and composition of a myofiber IS 
illustrated in Figure 21. Moreover, the fact that this staining pattern IS 
exhibited by isolated cells (Figure 19) suggests that the maintenance of this 
pattern may not depend on cell-cell adhesion. The NCAM subspecies 
containing the MSD region may rather participate in cell-extracellular matrix 
adhesion rather than cell-cell adhesion. 
Because previous studies of costameres were performed later in 
development (embryonic day 7 or later), we have prepared cardiomyocyte 
culture which represents the early or late stages of myofibrillogenesis. 
Myocardial cells are isolated from the stage 18 heart ventricle as described 
before. When these cells are observed early (day 1 or 2) in culture, the MSD-
containing NCAM species are exclusively colocalized at Z-discs (Figure 22, b) 
together with a-actinin (Figure 22, b). On the other hand, other molecules 
known to be associated with Z-discs later in development, ~1 integrin (Figure 
22, c), vinculin (Figure 22, e), or N-cadherin (Figure 22, f), are not yet found at 
Z discs. Vinculin finally associate with Z discs later in culture (day 4) showing 
the typical striated stripe pattern (Figure 23, d). While prevIous 
immunohistochemical studies have presented rather a complete picture of 
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Figure 22. Distributions of Adhesion Molecules and Cytoskeletal Proteins in 
Cultured Stage 18 Myocardial Cells. 
Cardiomyocytes are stained with the following antibodies: (a) anti-pan 
NCAM, (b) anti-12CD, (c) anti-~1 integrin, (d) anti-a-(sarcomeric) actinin, (e) 
anti-vinculin, and (f) anti-N-cadherin. Results show that the MSD+ NCAM 
are the only CAM colocalizing with a-actinin at Z-discs during the early 
assembly of myofibers in vitro. Size bar = 10 Jlm. 
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Figure 23. Immunohistochemistry of Cultured Myocardial Cells. 
Cardiomyocytes are isolated from stage 18 chicken heart, cultured for 1 or 4 days, and 
immunostained for various structural components of Z-disc. At cuture day 1, cells are detected 
by (a) anti-12CD, (b) anti-a-(sarcomeric) actinin, or (c) anti-vinculin. Cells are also detected by (d) 
anti-vinculin at the culture day 4. Note that the MSD-containing NCAMs are colocalized at the 
Z-disc earlier than vinculin. 
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costamere structure which contained many cytoplasmic elements including 
vinculin, actinin, and talin, our data indicates that a supposedly essential 
element (vinculin) is missing from the costamere at stage 18 whereas the 
MSD-positive NCAM is already present. Thus, our study indicates that the 
MSD-containing NCAM has become localized to the Z-disc region even 
before one of the supposedly essential structural element of costameres (i.e., 
vinculin) is assembled. 
62 
DISCUSSION 
Research Scheme to Study NCAM Containing MSD Region 
The NCAM gene is composed of a large transcriptional unit including 
19 major exons (Figure 2). Three major forms of NCAM are detected in 
tissues; the ld, sd, and ssd (Figure 1) variants that differ in their association to 
the plasma membrane. This structural diversity of NCAM polypeptides is 
generated by an alternative RNA splicing mechanism (56, 72, 79). Overall, 
three major forms of NCAM have been well identified in brain, heart, and 
muscle tissues. 
Heart, skeletal muscle, and skin NCAM molecules contain a MSD 
insert in the extracellular portion, while this insert is not present in brain 
NCAM (15, 43, 51, 72, 79). We have been particularly interested in studying 
the expression of MSD insert which is spliced into the NCAM protein by a 
tissue-specific mRNA splicing. The MSD insert is composed of 31 amino 
acids which are encoded by four additional small exons, A-D, located between 
exon 12 and 13 of the NCAM gene (Figure 3). 
In order to detect the MSD sequences contained In NCAM 
polypeptides, we have raised two polyclonal antibodies: one is anti-12AB 
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directed against the polypeptide encoded byexons 12A and B, the second is 
anti-12CD against the polypeptide encoded byexons 12C and D. We have 
divided the MSD into two regions because the 3' half of MSD shares higher 
homology across species than the 5' half; while the sequence of four small 
exons is highly conserved between humans, rats, and mice, two of the four 
chicken exons (12A and 12B) are very different in sequence from their 
mammalian counterparts (51). Therefore, two anti-MSD antibodies, each 
directed against a specific sequence, would be used for a cross-species study. In 
addition, these two antibodies would be able to detect if the microscale 
mRNA splicing occurs between exons 12 A-D. Some studies suggest that only 
exons 12A and 12D are expressed in the brain from the MSD region (26, 55, 
64), whereas that all four of these small exons (12A-D) are expressed in heart, 
skeletal muscle, and skin (15, 43, 51). 
Based on studies using the MSD-specific antibodies, I have made the 
following novel observations: 1) During heart development, all three splice 
variants of NCAM (ld, sd, and ssd) that differ in their mode of attachment to 
the plasma membrane are expressed both in forms containing and in forms 
lacking the MSD region. 2) At the protein level, the MSD region encoded by 
exons 12A, 12B, 12C, and 12D appears either to be absent or to be expressed in 
its entirety, i.e. we see no evidence for alternate splicing among these four 
small exons. 3) The six forms of NCAM detected in this study each change 
dramatically in their expression during development. In particular, the 
percentage of the ld, sd, or ssd form expressed that is also MSD region-positive 
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can vary nearly between a and 100 % in a temporally and spatially controlled 
manner. 4) At the immunohistochemical level, forms of NCAM containing 
the MSD region are specifically associated with Z discs early in heart 
development suggesting a role for this regIon of NCAM In 
myofibrillogenesis. 5) In cultured cardiomyocytes, the MSD-containing 
NCAM appear to be the earliest cell adhesion molecule that is associated with 
Z discs. This suggests that MSD-expressing NCAM plays a unique role in the 
J cell membrane and myofiber interaction at very early stages of muscle 
differentiation. 
MSD is Present in Many NCAM Splice Variant Forms 
Previous studies on forms of NCAM expressed in the developing 
chicken heart revealed 150, 140, and 130 kD polypeptides (30, 51). The 130 kD 
polypeptide was found to be GPI-linked to the plasma membrane and to be 
the predominant form of NCAM in adult heart while the 150 and 140 kD 
forms were predominant earlier in development. Those studies also have 
shown that the 180 kD and 140 kD transmembrane forms and the 120 kD GPI-
anchored form are present in neural tissue. Particularly, the 180 kD species 
was believed to be neural tissue-specific and has never been identified in 
other tissues (30). 
In the present study, we have been able to resolve and unambiguously 
identify six forms of NCAM during heart development (Table 2). 185 and 180 
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kD polypeptides have been shown to be variants of the ld (large cytoplasmic 
domain) form of NCAM because they are recognized by monoclonal antibody 
4d. 155 and 145 (previously referred to as 150 and 140) kD polypeptides are 
variants of the sd (small cytoplasmic domain) form of NCAM. 125 
, (previously referred to as 130) and 120 kD polypeptides are variants of the ssd 
(small surface domain) form of NCAM as evidenced by the fact that they are 
released from membranes by PIPLC (Table 1). In each of these pairs, the 
higher mol~cular weight forms (185, 155, and 125 kD) are recognized by anti-
MSD region antibodies, while the lower molecular weight forms (180, 145, 
and 120 kD) are not recognized by these antibodies. Thus, each splice variant 
of NCAM that differs in its attachment to the plasma membrane can also be 
expressed either containing or lacking the MSD region (Table 2). This 
interpretation of the identity of NCAM polypeptides is in agreement with the 
studies of Yoshimi et al. (78) on the 155 kD and 145 kD forms of NCAM 
expressed during skeletal muscle development. 
In previous studies of forms of NCAM expressed during heart 
development, the ld form observed was considered likely to be of neural 
origin. The current study suggests, however, that the ld form of NCAM is 
also expressed by heart tissue. First of all, the 185 and 180 kD forms of NCAM 
are present at significant levels even in stage 15 (unpublished data by V. 
Mironov: personal communication) chicken embryos, and these forms peak 
in expression in 7 day embryos (Figure 14). If these forms of NCAM were 
expressed by the cells that innervate the heart, they might be expected to 
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appear later and to be maintained throughout development. Second, the 185 
kD form of NCAM is recognized by anti-MSD region antibodies even though 
these antibodies do not recognize any form of NCAM in the brain. Assuming 
that the innervation of the heart is similar to the brain in not expressIng 
forms of NCAM recognized by anti-MSD antibodies, then our data would 
suggest that at least the 185 kD form of NCAM is produced within the 
musculature of the heart. It is tempting to speculate that the Id form of 
NCAM may be preferentially expressed in the conduction system, given that 
the polysialic moieties found on NCAM as well as the carbohydrate epitopes 
recognized by monoclonal antibody HNK-l and found on neural NCAM and 
other neural adhesion molecules are also preferentially expressed in this 
region of the heart (47, 77). 
No Heterogeneity within the MSD Sequence 
Data from PCR amplification of cDNAs prepared from developing rat 
heart mRNAs have suggested that alternative splicing occurs between exons 
12A, 12B, 12C, and 12D, and that these four small exons are present together 
in only a small percentage of NCAM mRNAs (56). Our results provide a very 
different picture for NCAM molecules at the protein level. Even at the level 
of CNBr fragments, we see that anti-12AB and anti-12CD recognize the same 
polypeptide and that there is no apparent heterogeneity in the size of this 
polypeptide. Because exons 12A and 12D are very small, we may not have 
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been able to detect their alternative splicing at the protein level; however, we 
should have been able to detect alternative splicing of exons 12B and 12C 
because they encode sufficient mass (11 or 14 amino acids) to noticeably affect 
the migration of a 45 kD CNBr fragment. The PCR data of Reyes et al. (56) 
indicate that about 70 % of the NCAM mRNA obtained from perinatal rat 
hearts lacks both exons 12B and 12C and that only 8 to 15 % (depending on 
whether ld, sd, or ssd molecules are being considered) contains both 12B and 
12C. In confrast, at the protein level, we find that for ld, sd, and ssd NCAM, 
forms of the molecule containing the MSD region represent at least 50 % of 
the NCAM molecules present in the heart from stage 15 embryos through 
adults. Moreover, the great majority of NCAM molecules contain the MSD 
region in 10 and 14-day embryos and in adults. This difference between our 
results and the results of Reyes et al. (56) may be due to species differences, 
differences in message stability or the ability of messages to be translated, or to 
differences in the half-life of the various polypeptides. 
Subcellular Localization of the MSD containing NCAM at the Z-Disc 
In the heart, we find a surprising difference in the regional expression 
of forms of NCAM containing and lacking the MSD regIon In 
immunohistochemical experiments. Extracts of atrioventricular endocardial 
cushion tissue included very little NCAM containing the MSD regIon. 
Moreover, all the MSD region-containing NCAM in these samples may be 
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derived from myocardial contamination; only the sd form of NCAM lacking 
the MSD region is present in Western blots of cultured endocardial and 
mesenchymal cells (Mironov, V., R.R. Markwald, and S. Hoffman; 
unpublished observations). In contrast, extracts of ventricle showed equal 
levels of NCAM molecules containing and lacking the MSD region. 
Similarly, immunohistochemical analyses showed NCAM molecules 
containing the MSD region to be present in the myocardium but absent from 
or present at only low levels in tissues of endocardial origin. Typically, like 
other molecules involved in cell-cell adhesion, NCAM is known to be 
expressed uniformly on the cell perimeter at all sites of cell-cell contact 
throughout heart development. Our discovery on the subcellular 
distribution of NCAM molecules containing the MSD region is, therefore, 
even more striking in that the MSD containing NCAM are expressed at sites 
of cell surface that are distinct from the sites of NCAM species lacking this 
insert; the MSD-containing NCAM are colocalized with the Z discs of 
myofibrils which is detected by staining with anti-a-(sarcomeric) actinin. It is 
clear that the structures recognized by anti-12CD that colocalize with Z discs 
must be NCAM molecules containing the MSD region because anti-12CD 
staining is blocked by preincubation of the antibody with the peptide against 
which it was made or by preincubation of the tissue section with the pan 
NCAM antibody (data not shown). 
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We speculate that the structure with which forms of NCAM 
containing the MSD region are colocalized at the cell membrane is the 
~costamere' (48). The costamere is a structure linking the cell membrane and 
subcellular Z discs and found in the striated and cardiac muscle (12)' 34/ 63)' 73). 
It is a composite structure containing many cytoplasmic structural elements 
including vinculin, meta-vinculin), desmin, talin, and a-actinin (34/ 63/ 73). 
When these structural components are immunostained), the costamere is 
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visualized as arrays of periodic), rib-like, repeating lattice pattern beneath the 
cell membrane. A major role of the costamere is to connect the Z-discs of 
myofibrils to the sarcolemma and to stabilize their association (48). The role 
of costamere structure appears to be to provide more than a mechanophysical 
support to the cell. That is, costameres also play a role in transducing 
extracellular signals into the cells (4). 
Recent studies show that cell adhesion molecules mediating ECM-
cytoskeleton signalling at the cell surface play important functions in the 
organization of the muscle contractile apparatus. Adhesion molecules such 
as av)' a3, ~1 integrin and N-cadherin are localized to Z discs while muscle 
differentiates (4)' 23, 29, 37, 44). In vitro inhibition studies demonstrate that 
elimination of certain cell to cell or cell to matrix interactions on 
cardiomyocytes using N-cadherin and ~1 integrin antibodies result In 
myofibril disassembly and sarcomerIC misalignment in vitro (23)' 29). This 
indicates that i) cytoskeletal contraction is highly dependent on the 
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organization of actin and myosIn, ii) cells respond to changes in the 
extracellular milieu by dynamically reorganizing the intracellular actin 
network, iii) cell adhesion molecules transduce signals received from the 
ECM to the Z disc, and iv) Z discs comprise an essential element of 
costameres. 
Our study, however, does not detect ~1 integrin and N-cadherin in 
association with Z discs at stage 18 when we do detect the MSD-positive 
NCAM. That is, the MSD-containing NCAM species are already localized at 
the Z-discs before other structural component of Z-discs (i.e., vinculin) and 
other adhesion molecules are expressed at the same spot. These observations 
make NCAM molecules containing the MSD region the earliest-appearing 
cell-surface adhesion molecule detected in association with Z discs. This leads 
to our speculation that the NCAM subspecies containing the MSD region may 
playa key function in the earliest stages of cardiomyofibrillogenesis. 
Models for the NCAM Interaction with the Muscle Z-Disc 
This study provides two striking insights regarding the role of MSD 
region-containing NCAM in cellular interactions and in the mechanism of its 
linkage to the cytoskeleton. 1) NCAM is well known to be a myocardial cell-
cell adhesion molecule and is usually observed at sites of cell-cell contact in 
immunohistological studies. The highlight of our study is that we find that 
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the MSD-containing NCAM subspecies are uniquely associated with Z-discs. 
Therefore, our observations suggest that MSD NCAM plays a special role in 
the mechanical integration of muscle contractile components with the cell 
membrane. Although NCAM is usually involved in cell-cell adhesion, our 
observations raise the possibility that cell-cell adhesion does not playa role in 
the colocalization of MSD region-containing NCAM with Z discs. In vivo, 
MSD region-containing NCAM is localized in register with Z discs and not in 
a uniform distribution on the cell surface or in intercalated discs as would be 
expected for a molecule involved in cell-cell adhesion. In vitro, MSD region-
containing NCAM can become colocalized with Z discs in isolated cells where 
little, if any, of the cell surface is involved in cell-cell contact. These 
observations raise the possibility that MSD region-containing NCAM is 
involved In cell-ECM adhesion. This would be consistent with scanning 
electron microscopic studies that show collagen-containing 'struts' of 
connective tissue that interact with the myocardial cell surface In register 
with Z discs (5). Previously, Walsh (75) has recognized the importance of 
MSD located in a hinge region of NCAM polypeptide. He speculated that the 
inclusion of a small MSD insert would transform the existing NCAM into a 
more flexible structure. This indicates that such a change may affect the 
binding specificity of NCAM (75). 2) NCAM molecules containing the MSD 
region are identical in the primary structure of their cytoplasmic region with 
NCAM molecules lacking the MSD region. Nevertheless, the MSD region-
containing molecules appear to interact with the cytoskeleton in a manner 
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that results in their colocalization with Z discs while molecules lacking the 
MSD region do not interact with the cytoskeleton in this manner. This 
suggests two models depicted in Figure 24. Either the interaction of MSD 
region-containing NCAM with an ECM ligand alters the conformation of the 
cytoplasmic tail of NCAM resulting in its ability to bind to a component of Z 
discs (Figure 24, A) or MSD region-containing NCAM molecules can interact 
with a protein in the same cell (cis ligand) that possesses the ability to bind to 
a component of Z discs (Figure 24, B). Of course, more complicated models 
are also possible; for example, the interaction of MSD region-containing 
NCAM with a cis ligand might induce the ability of the NCAM or of the cis 
ligand to interact with Z discs. Whether MSD region-containing NCAM 
interacts with an ECM ligand or a cis ligand, the interactive portion of the 
MSD region may lie in its amino-acid sequence or in the O-linked 
carbohydrate [recognized by peanut lectin following neuraminidase treatment 
of the molecule (75)] associated with the MSD region. 
Based upon the restricted localization of MSD-containing NCAM at Z-
discs observed in heart tissue as well as in isolated cardiomyocytes, we 
propose that this NCAM species playa role in muscle tissue differentiation. 
More specifically, the fact that MSD-containing NCAM colocalizes with the Z-
disc at very early stages of myofibrillogenesis suggests that this form of 
NCAM serves as a structural backbone for the molecular assembly of Z-discs. 
We also speculate that this MSD-containing NCAM plays an active role in 
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Figure 24. Models for the Mechanism whereby NCAM Containing the MSD 
Region is Specifically Associated with Z Discs. 
The MSD region and its covalently attached O-linked oligosaccharide is 
represented by a filled circle. Ligands recognizing the MSD region are 
depicted with a complementary shape. In model A, the interaction of an ECM 
ligand with the MSD region induces a conformational change in the 
cytoplasmic tail of NCAM allowing it to bind to the Z discs. NCAM 
molecules lacking the MSD region cannot bind this ECM ligand and therefore 
cannot undergo the conformational change that allows them to dock in Z 
discs. In model B, a cis ligand (present in the plasma membrane of the same 
cell) binds both to the MSD region and to the Z disc. NCAM molecules 
lacking the MSD region do not bind to this cis ligand and do not become 
associated with Z discs. 
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transmembrane signal transduction via its interaction with components of Z-
discs. 
The current study demonstrates the feasibility and utility of uSIng 
antibodies against alternatively spliced regions in NCAM to evaluate their 
identity and distributions in vivo. The existence of the MSD region in 
NCAM was deduced from molecular biological studies. However, such 
studies did not indicate precisely which mRNAs detected on Northern blots 
using MSD region-specific probes encode which NCAM polypeptides 
observed on Western blots. Molecular biological studies also did not and 
cannot indicate the subcellular distribution of forms of NCAM containing the 
MSD region. The antibodies prepared in the current study have allowed the 
identification and characterization on Western blots of the forms of NCAM 
containing the MSD region. Moreover, these antibodies have allowed us to 
make the striking observation that forms of NCAM containing the MSD 
region are colocalized with Z discs and thus are likely to be involved in 
myofibrillogenesis. Antibodies specific for other splice variants of NCAM 
(e.g. ld and ssd forms and forms containing the VASE insert) may be equally 
useful for determining the distribution in vivo of particular forms of NCAM 
and thereby suggesting specialized functions for each of these forms. 
Future Studies on the NCAM Containing MSD 
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In the current study, we have prepared antibodies against two 
oligopeptides that together comprise the MSD region of chicken NCAM. 
These antibodies have allowed us to analyze the expression of forms of 
NCAM in heart development. We find that all ld, sd, and ssd forms of 
NCAM can contain or lack this MSD insert. During heart development, six 
various forms of NCAM dramatically change their temporal and spatial 
patterns of expression. Specially, expression modes of NCAM speCIes 
containing· the MSD sequence are precisely correlated to myofiber 
differentiation of heart. These findings are reproduced in the cardiomyocyte 
culture making MSD-positive NCAM the earliest adhesion molecule 
localized at the Z disc region. We therefore propose new models of NCAM 
interaction and suggest that the MSD-containing NCAM species playa role in 
myofibrillogenesis. 
Finally, I would like to suggest future follow-up studies for NCAM 
containing the MSD insert. i) Transgenic or gene knock-out experiment: As 
for the loss of MSD function, a mouse can be produced via targeted disruption 
of the MSD sequence in NCAM (knock-out). Likewise, a knock-in mouse 
with over (redundant)-expressed MSD in NCAM species can be created. 
These studies would be invaluable in understanding the role of MSD. ii) The 
mechanism of MSD splicing: Though the MSD expression is highly tissue-
specific, how its mRNA splicing is regulated at these tissues is not known. 
This study would be important in understanding the molecular genetics and 
the diversity of NCAM . 
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